ID   HUTH_RAT                Reviewed;         657 AA.
AC   P21213; Q5EBB8;
DT   01-MAY-1991, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1991, sequence version 1.
DT   02-OCT-2024, entry version 149.
DE   RecName: Full=Histidine ammonia-lyase;
DE            Short=Histidase;
DE            EC=4.3.1.3;
GN   Name=Hal; Synonyms=Huth;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND PARTIAL PROTEIN SEQUENCE.
RC   STRAIN=Sprague-Dawley; TISSUE=Liver;
RX   PubMed=2120224; DOI=10.1016/s0021-9258(17)44737-5;
RA   Taylor R.G., Lambert M.A., Sexsmith E., Sadler S.J., Ray P.N.,
RA   Mahuran D.J., McInnes R.R.;
RT   "Cloning and expression of rat histidase. Homology to two bacterial
RT   histidases and four phenylalanine ammonia-lyases.";
RL   J. Biol. Chem. 265:18192-18199(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Liver;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   CATALYTIC ACTIVITY, ENZYME MECHANISM, AND MUTAGENESIS OF SER-254.
RX   PubMed=7961661; DOI=10.1016/s0021-9258(18)47009-3;
RA   Taylor R.G., McInnes R.R.;
RT   "Site-directed mutagenesis of conserved serines in rat histidase.
RT   Identification of serine 254 as an essential active site residue.";
RL   J. Biol. Chem. 269:27473-27477(1994).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-635 AND SER-648, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-histidine = NH4(+) + trans-urocanate; Xref=Rhea:RHEA:21232,
CC         ChEBI:CHEBI:17771, ChEBI:CHEBI:28938, ChEBI:CHEBI:57595; EC=4.3.1.3;
CC         Evidence={ECO:0000255|PROSITE-ProRule:PRU10122,
CC         ECO:0000269|PubMed:7961661};
CC   -!- PATHWAY: Amino-acid degradation; L-histidine degradation into L-
CC       glutamate; N-formimidoyl-L-glutamate from L-histidine: step 1/3.
CC   -!- TISSUE SPECIFICITY: Liver and skin.
CC   -!- PTM: Contains an active site 4-methylidene-imidazol-5-one (MIO), which
CC       is formed autocatalytically by cyclization and dehydration of residues
CC       Ala-Ser-Gly. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the PAL/histidase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M58308; AAA63491.1; -; mRNA.
DR   EMBL; BC089809; AAH89809.1; -; mRNA.
DR   PIR; A36087; A36087.
DR   RefSeq; NP_058855.1; NM_017159.1.
DR   AlphaFoldDB; P21213; -.
DR   SMR; P21213; -.
DR   DIP; DIP-37290N; -.
DR   IntAct; P21213; 1.
DR   STRING; 10116.ENSRNOP00000006971; -.
DR   iPTMnet; P21213; -.
DR   PhosphoSitePlus; P21213; -.
DR   PaxDb; 10116-ENSRNOP00000006971; -.
DR   Ensembl; ENSRNOT00000006971.7; ENSRNOP00000006971.4; ENSRNOG00000004502.7.
DR   Ensembl; ENSRNOT00055009508; ENSRNOP00055007321; ENSRNOG00055005880.
DR   Ensembl; ENSRNOT00060047906; ENSRNOP00060039850; ENSRNOG00060027612.
DR   Ensembl; ENSRNOT00065019927; ENSRNOP00065015276; ENSRNOG00065012257.
DR   GeneID; 29301; -.
DR   KEGG; rno:29301; -.
DR   UCSC; RGD:68363; rat.
DR   AGR; RGD:68363; -.
DR   CTD; 3034; -.
DR   RGD; 68363; Hal.
DR   eggNOG; KOG0222; Eukaryota.
DR   GeneTree; ENSGT00390000009047; -.
DR   HOGENOM; CLU_014801_4_0_1; -.
DR   InParanoid; P21213; -.
DR   OMA; YSLRCMP; -.
DR   OrthoDB; 1030318at2759; -.
DR   PhylomeDB; P21213; -.
DR   TreeFam; TF313824; -.
DR   Reactome; R-RNO-70921; Histidine catabolism.
DR   UniPathway; UPA00379; UER00549.
DR   PRO; PR:P21213; -.
DR   Proteomes; UP000002494; Chromosome 7.
DR   Bgee; ENSRNOG00000004502; Expressed in liver and 1 other cell type or tissue.
DR   GO; GO:0005737; C:cytoplasm; IEA:InterPro.
DR   GO; GO:0004397; F:histidine ammonia-lyase activity; IDA:RGD.
DR   GO; GO:0006548; P:L-histidine catabolic process; ISO:RGD.
DR   GO; GO:0019556; P:L-histidine catabolic process to glutamate and formamide; IEA:UniProtKB-UniPathway.
DR   GO; GO:0019557; P:L-histidine catabolic process to glutamate and formate; IEA:UniProtKB-UniPathway.
DR   GO; GO:0006547; P:L-histidine metabolic process; TAS:RGD.
DR   CDD; cd00332; PAL-HAL; 1.
DR   Gene3D; 1.20.200.10; Fumarase/aspartase (Central domain); 1.
DR   Gene3D; 1.10.275.10; Fumarase/aspartase (N-terminal domain); 1.
DR   InterPro; IPR001106; Aromatic_Lyase.
DR   InterPro; IPR024083; Fumarase/histidase_N.
DR   InterPro; IPR005921; HutH.
DR   InterPro; IPR008948; L-Aspartase-like.
DR   InterPro; IPR021922; Par3/HAL_N.
DR   InterPro; IPR022313; Phe/His_NH3-lyase_AS.
DR   NCBIfam; TIGR01225; hutH; 1.
DR   PANTHER; PTHR10362; HISTIDINE AMMONIA-LYASE; 1.
DR   PANTHER; PTHR10362:SF7; HISTIDINE AMMONIA-LYASE; 1.
DR   Pfam; PF00221; Lyase_aromatic; 1.
DR   Pfam; PF12053; Par3_HAL_N_term; 1.
DR   SUPFAM; SSF48557; L-aspartase-like; 1.
DR   PROSITE; PS00488; PAL_HISTIDASE; 1.
PE   1: Evidence at protein level;
KW   Direct protein sequencing; Histidine metabolism; Lyase; Phosphoprotein;
KW   Reference proteome.
FT   CHAIN           1..657
FT                   /note="Histidine ammonia-lyase"
FT                   /id="PRO_0000161060"
FT   MOD_RES         254
FT                   /note="2,3-didehydroalanine (Ser)"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10122"
FT   MOD_RES         396
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P35492"
FT   MOD_RES         635
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         637
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P35492"
FT   MOD_RES         648
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   CROSSLNK        253..255
FT                   /note="5-imidazolinone (Ala-Gly)"
FT                   /evidence="ECO:0000250"
FT   MUTAGEN         223
FT                   /note="S->A: 2.4% of activity."
FT   MUTAGEN         254
FT                   /note="S->A: Complete loss of activity."
FT                   /evidence="ECO:0000269|PubMed:7961661"
FT   MUTAGEN         508
FT                   /note="S->A: 75% of activity."
FT   MUTAGEN         533
FT                   /note="S->A: 16% of activity."
SQ   SEQUENCE   657 AA;  72284 MW;  CBED79FC6CD40FA0 CRC64;
     MPRYTVHVRG EWLAVPCQDG KLSVGWLGRE AVRRYMKNKP DNGGFTSVDE VRFLVRRCKG
     LGLLDNEDLL EVALEDNEFV EVVIEGDVMS PDFIPSQPEG VFLYSKYREP EKYIALDGDS
     LSTEDLVNLG KGHYKIKLTS IAEKKVQQSR EVIDSIIKER TVVYGITTGF GKFARTVIPA
     NKLQELQVNL VRSHSSGVGK PLSPERCRML LALRINVLAK GYSGISLETL KQVIEVFNAS
     CLSYVPEKGT VGASGDLAPL SHLALGLIGE GKMWSPKSGW ADAKYVLEAH GLKPIVLKPK
     EGLALINGTQ MITSLGCEAV ERASAIARQA DIVAALTLEV LKGTTKAFDT DIHAVRPHRG
     QIEVAFRFRS LLDSDHHPSE IAESHRFCDR VQDAYTLRCC PQVHGVVNDT IAFVKDIITT
     ELNSATDNPM VFASRGETIS GGNFHGEYPA KALDYLAIGV HELAAISERR IERLCNPSLS
     ELPAFLVAEG GLNSGFMIAH CTAAALVSES KALCHPSSVD SLSTSAATED HVSMGGWAAR
     KALRVIEHVE QVLAIELLAA CQGIEFLRPL KTTTPLEKVY DLVRSVVRPW IKDRFMAPDI
     EAAHRLLLDQ KVWEVAAPYI EKYRMEHIPE SRPLSPTAFS LESLRKNSAT IPESDDL
//
